评估与优化人类免疫缺陷病毒感染者的心肌梗死风险估计:艾滋病研究中心综合临床系统网络研究
在美国5个艾滋病研究中心网络综合临床系统站点、19 829例HIV感染成人的多中心前瞻性队列中,评估标准治疗与2个新数据衍生心梗风险模型的表现。2013年汇总队列方程对心梗风险有足够区分度(Harrell C统计量=0.75;95%CI,0.71-0.78),两个纳入HIV特异性协变量的数据衍生模型验证样本校准弱且区分度未更优。汇总队列方程校准中等但一致低估心梗发生率。
要点
- 2013年汇总队列方程对HIV感染者心梗风险区分度足够(C统计量=0.75;95%CI,0.71-0.78)。
- 两个数据衍生模型验证样本校准弱,区分度未优于汇总队列方程。
- 汇总队列方程在艾滋病研究中心网络校准中等但一致低估心梗发生率。
核心结论
- 汇总队列方程在该多中心HIV队列中区分心梗风险且校准中等。
- 添加HIV特异性因素未改善模型表现。
- 随着HIV感染队列捕获和评估心梗与卒中结局,研究者应重新审视风险估计工具的表现。
研究设计与样本
- 在美国5个艾滋病研究中心网络综合临床系统站点开展的多中心临床前瞻性队列,自1995年起纳入19 829例HIV感染成人,在住院和门诊接受治疗。
- 评估标准治疗与2个新数据衍生心梗风险估计模型的表现,新模型在独立于推导队列的验证队列中验证。
主要发现
- 基线数据完整的11 288例患者中,6904例为白人,9250例为男性。
- 黑种人男性心梗率为6.9/1000人年、黑种人女性为7.2/1000人年,高于白种人男性的4.4/1000人年和白种人女性的3.3/1000人年。
- 研究入组时年龄≥40岁成人心梗率为7.5/1000人年,高于<40岁成人的2.2/1000人年。
- 可检出病毒载量者心梗率为6.3/1000人年,高于不可检出者的4.7/1000人年。
- 2013年汇总队列方程预测心梗与卒中复合率,对心梗风险区分度足够(Harrell C统计量=0.75;95%CI,0.71-0.78)。
关键数值与推荐
- 两个纳入HIV特异性协变量的数据衍生模型在验证样本中校准弱,区分度分别为Harrell C统计量=0.72(95%CI,0.67-0.78)和0.73(95%CI,0.68-0.79),均未优于汇总队列方程。
- 汇总队列方程在艾滋病研究中心网络综合临床系统中校准中等,但一致预测较低的心梗发生率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Persons with human immunodeficiency virus (HIV) that is treated with antiretroviral therapy have improved longevity but face an elevated risk of myocardial infarction (MI) due to common MI risk factors and HIV-specific factors. Despite these elevated MI rates, optimal methods to predict MI risks for HIV-infected persons remain unclear. OBJECTIVE: To determine the extent to which existing and de novo estimation tools predict MI in a multicenter HIV cohort with rigorous MI adjudication. DESIGN, SETTING, AND PARTICIPANTS: We evaluated the performance of standard of care and 2 new data-derived MI risk estimation models in 5 Centers for AIDS Research Network of Integrated Clinical Systems sites across the United States where a multicenter clinical prospective cohort of 19 829 HIV-infected adults received care in inpatient and outpatient settings since 1995. The new risk estimation models were validated in a separate cohort from the derivation cohort. EXPOSURES: Traditional cardiovascular risk factors, HIV viral load, CD4 lymphocyte count, statin use, antihypertensive use, and antiretroviral medication use were used to calculate predicted event rates. MAIN OUTCOMES AND MEASURES: We observed MI rates over the course of follow-up that were scaled to 10 years using the Greenwood-Nam-D'Agostino Kaplan-Meier approach to account for dropout and loss to follow-up before 10 years. RESULTS: Of the 11 288 patients with complete baseline data, 6904 were white and 9250 were men. Myocardial infarction rates were higher among black men (6.9 per 1000 person-years) and black women (7.2 per 1000 person-years) than white men (4.4 per 1000 person-years) and white women (3.3 per 1000 person-years), older participants (7.5 vs 2.2 MI per 1000 person-years for adults 40 years and older vs < 40 years old at study entry, respectively), and participants who were not virally suppressed (6.3 vs 4.7 per 1000 person-years for participants with and without detectable viral load, respectively). The 2013 Pooled Cohort Equations, which predict composite rates of MI and stroke, adequately discriminated MI risk (Harrell C statistic = 0.75; 95% CI, 0.71-0.78). Two data-derived models incorporating HIV-specific covariates exhibited weak calibration in a validation sample and did not discriminate risk any better (Harrell C statistic = 0.72; 95% CI, 0.67-0.78 and 0.73; 95% CI, 0.68-0.79) than the Pooled Cohort Equations. The Pooled Cohort Equations were moderately calibrated in the Centers for AIDS Research Network of Clinical Systems but predicted consistently lower MI rates. CONCLUSIONS AND RELEVANCE: The Pooled Cohort Equations discriminated MI risk and were moderately calibrated in this multicenter HIV cohort. Adding HIV-specific factors did not improve model performance. As HIV-infected cohorts capture and assess MI and stroke outcomes, researchers should revisit the performance of risk estimation tools.
引用
- Feinstein MJ, Nance RM, Drozd DR, et al. Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems. JAMA Cardiol. 2017. PMID: 28002550. doi:10.1001/jamacardio.2016.4494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。